STOCK TITAN

Genmab A/S (GMAB): Orbis and Allan Gray report 5.3% beneficial ownership stake

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd report beneficial ownership in Genmab A/S. The reporting persons together beneficially own 3,328,505 Ordinary Shares, consisting of 2,191,689 Ordinary Shares and 11,368,161 ADSs representing 1,136,816 Ordinary Shares.

This position represents 5.3% of Genmab’s outstanding Ordinary Shares. Orbis Investment Management Ltd holds sole voting and dispositive power over 3,320,695 shares, while Allan Gray Australia Pty Ltd holds sole voting and dispositive power over 7,810 shares. Other persons have rights to dividends and sale proceeds associated with these securities. Each reporting person disclaims beneficial ownership of shares reported by the other and states that the joint filing does not constitute a "group" under Section 13(d)(3).

Positive

  • None.

Negative

  • None.
Beneficial ownership 3,328,505 Ordinary Shares Total beneficially owned by Orbis and Allan Gray together
Ownership percentage 5.3 % Percent of Genmab A/S Ordinary Shares class
Ordinary Shares held directly 2,191,689 Ordinary Shares Portion of total beneficial ownership held as Ordinary Shares
ADSs held 11,368,161 ADSs ADS component of beneficial ownership, each 10 ADSs = 1 Ordinary Share
Orbis sole voting power 3,320,695 shares Shares over which Orbis has sole voting and dispositive power
Allan Gray sole voting power 7,810 shares Shares over which Allan Gray Australia Pty Ltd has sole voting and dispositive power
American Depositary Shares (ADS) financial
"Ordinary Shares and American Depositary Shares (ADS), each 10 ADS representing 1 Ordinary Share"
American depositary shares (ADS) are a way for investors in the United States to buy shares of foreign companies without dealing with the complexities of international markets. They represent ownership in a foreign company's stock and are traded on U.S. exchanges, making it easier and more convenient for Americans to invest internationally. ADSs allow investors to diversify their portfolios with foreign companies while using familiar trading platforms.
beneficially owned financial
"Amount beneficially owned: 3,328,505, made up of 2,191,689 Ordinary Shares and 11,368,161 ADSs"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Non-U.S. Institution (FI) regulatory
"Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd are classified as a Non-U.S. Institution (FI)"
Investment Adviser (IA) regulatory
"Non-U.S. Institution (FI) that is equivalent to an Investment Adviser (IA)"
An investment adviser (IA) is a person or firm that provides personalized guidance on buying, selling, or holding investments and often manages client portfolios for a fee. Investors should care because an IA has a legal duty to act in the client's best interest—think of them as a navigator who plans and steers your financial journey—so their advice, fee structure and potential conflicts can directly affect returns and financial risk.
Schedule 13D regulatory
"undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D"
A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.

FAQ

What ownership stake in Genmab A/S (GMAB) do Orbis and Allan Gray report?

Orbis Investment Management Ltd and Allan Gray Australia Pty Ltd report beneficial ownership of 3,328,505 Ordinary Shares of Genmab A/S, representing 5.3% of the outstanding class as disclosed under Schedule 13G/A.

How is the 3,328,505-share position in Genmab A/S (GMAB) structured?

The reported 3,328,505 Ordinary Shares consist of 2,191,689 Ordinary Shares and 11,368,161 ADSs, with each 10 ADSs representing 1 Ordinary Share, corresponding to 1,136,816 Ordinary Shares via ADSs.

What portion of Genmab A/S (GMAB) shares does Orbis control directly?

Orbis Investment Management Ltd has sole voting and dispositive power over 3,320,695 shares, made up of 2,187,218 Ordinary Shares and 11,334,768 ADSs, which represent 1,133,477 Ordinary Shares through ADSs.

What holdings in Genmab A/S (GMAB) are reported by Allan Gray Australia Pty Ltd?

Allan Gray Australia Pty Ltd has sole voting and dispositive power over 7,810 shares, consisting of 4,471 Ordinary Shares and 33,393 ADSs, which represent 3,339 Ordinary Shares via ADSs, according to the Schedule 13G/A.

Do Orbis and Allan Gray form a group for Genmab A/S (GMAB) under Section 13(d)?

The reporting persons state that, despite filing together, none of them represents that it is a member of a group for purposes of Section 13(d)(3) and each disclaims beneficial ownership of shares held by the other.

Who has rights to dividends and sale proceeds from the Genmab A/S (GMAB) shares?

The filing notes that other persons have the right to receive dividends or sale proceeds for securities beneficially owned by Orbis and Allan Gray, reflecting underlying clients’ economic interests in these positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





K3967W102

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



ORBIS INVESTMENT MANAGEMENT LTD
Signature:Matthew Gaarder
Name/Title:Attorney-in-Fact
Date:08/14/2026
Allan Gray Australia Pty Ltd
Signature:Matthew Gaarder
Name/Title:Attorney-in-Fact
Date:08/14/2026